scispace - formally typeset
Search or ask a question
Institution

Ochsner Medical Center

HealthcareNew Orleans, Louisiana, United States
About: Ochsner Medical Center is a healthcare organization based out in New Orleans, Louisiana, United States. It is known for research contribution in the topics: Population & Medicine. The organization has 980 authors who have published 1159 publications receiving 49961 citations. The organization is also known as: Ochsner Hospital & Ochsner Foundation Hospital.


Papers
More filters
Journal ArticleDOI
TL;DR: It is suggested that early use of steroids during CPI treatment significantly hinders CPI efficacy, and future studies should focus on the immune mechanisms by which CS affect T-cell function early in CPI treatment course.
Abstract: Background Corticosteroids (CS) are the mainstay of immune-related adverse effect (irAE) management, as well as for other indications in cancer treatment. Previous studies evaluating whether CS affect immune checkpoint inhibitor (CPI) efficacy compared patients receiving steroids vs. no steroids.1 This comparison may be confounded by different rates of irAEs, which are known to be associated with higher response rates to CPIs. Preclinically CS have been shown to diminish naive T-cell proliferation and differentiation,2 though there is a paucity of clinical data evaluating how the timing of concomitant CS affects CPI efficacy. Methods We retrospectively collected data from patients treated with CPIs alone, who received CS during their CPI treatment at a single institution. Patients were allocated into two cohorts based on timing of initiation of CS (> 2 months vs. Results We identified 247 patients with metastatic cancer who received CS concurrently with CPIs alone. The majority of patients had non-small cell lung cancer (n=98), followed by renal cell carcinoma (n=43), and melanoma (n=30). 242 patients were on PD-1 inhibitor monotherapy, while 45 patients received CPI in combination with anti-CTLA-4 ipilimumab (table 1). The median time on steroids for all patients was 1.8 months. After adjusting for differences in rates of treatment type, tumor type, brain metastases and irAEs, patients who were treated with CS > 2 months after starting CPI had a statistically significant longer progression free survival (PFS) [HR of 0.33, p≤0.0001], and overall survival (OS) [HR of 0.36, p≤0.0001] than those who received steroids 2 months was 39.8%, vs. ORR for patients Conclusions After adjusting for possible confounding factors such as rates of irAEs, our results suggest that early use of steroids during CPI treatment significantly hinders CPI efficacy. These data need to be validated prospectively. Future studies should focus on the immune mechanisms by which CS affect T-cell function early in CPI treatment course. References Garant A, Guilbault C, Ekmekjian T, Greenwald Z, Murgoi P, & Vuong T. ( 2017). Concomitant use of corticosteroids and immune checkpoint inhibitors in patients with hematologic or solid neoplasms: a systematic review. Critical reviews in oncology/hematology120, 86–92. Giles AJ, Hutchinson MKN, Sonnemann HM, Jung J, Fecci PE, Ratnam NM,. .. & Reid CM. Dexamethasone-induced immunosuppression: mechanisms and implications for immunotherapy. Journal for immunotherapy of cancer 2018;6(1):1–13.
Journal ArticleDOI
TL;DR: The SCAI Publications Committee concisely summarizes and provides editorial commentary on the most important structural heart and peripheral arterial disease trials from the large international meetings of 2014 to allow quick assimilation of trial results into interventional practice.
Abstract: With the plethora of clinical trials, it is difficult for busy interventional cardiologists to stay up to date. Therefore, the SCAI Publications Committee concisely summarizes and provides editorial commentary on the most important structural heart and peripheral arterial disease trials from the large international meetings of 2014. The intent is to allow quick assimilation of trial results into interventional practice. © 2015 Wiley Periodicals, Inc.
Book ChapterDOI
05 Jul 2022
TL;DR: In this article , the authors look at the history and pros and cons of TIF when it comes to community redevelopment and how it has benefited and benefits CRED, and discuss the advantages and disadvantages of using tax increment financing in community development.
Abstract: One of the most important aspects of community development is the notion of private public partnerships in which a government entity partners with a private sector developer to complete a development that neither could have done on their own. One of the most widely used forms of public-private partnership development agreements is tax increment financing, better known as TIF. This chapter looks at the history and pros and cons of TIF when it comes to community redevelopment and how it has benefited and benefits CRED.

Authors

Showing all 993 results

NameH-indexPapersCitations
Carl J. Lavie106113549318
Michael R. Jaff8244228891
Michael F. O'Rourke8145135355
Mandeep R. Mehra8064431939
Richard V. Milani8045423410
Christopher J. White7762125767
Bruce A. Reitz7433318457
Robert C. Bourge6927324397
Sana M. Al-Khatib6937717370
Hector O. Ventura6647816379
Andrew Mason6336015198
Aaron S. Dumont6038613020
Philip J. Kadowitz5537911951
David W. Dunn541958999
Lydia A. Bazzano5126713581
Network Information
Related Institutions (5)
Henry Ford Hospital
12.4K papers, 465.3K citations

80% related

Cleveland Clinic
79.3K papers, 3.4M citations

77% related

Cedars-Sinai Medical Center
26.4K papers, 1.2M citations

77% related

Vanderbilt University Medical Center
34.6K papers, 1.1M citations

76% related

Hospital of the University of Pennsylvania
14K papers, 459.9K citations

76% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20231
202223
2021120
2020117
2019102
201886